StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)

Close on Nov 17, 2026Market cap $11.21MP/E –Yield –

Bionano Genomics gross margin

Gross margin is gross profit as a percentage of revenue.

Bionano Genomics's gross margin for the twelve months ending Jun 30, 2026 was 47.5%. For fiscal 2025 it was 46.3%, against 1.2% the year before. The highest annual figure on record is 46.3% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202546.3%+45.0
FY2024Dec 31, 20241.2%−25.3
FY2023Dec 31, 202326.5%+5.1
FY2022Dec 31, 202221.4%−0.2
FY2021Dec 31, 202121.5%−11.1
FY2020Dec 31, 202032.6%−0.6
FY2019Dec 31, 201933.2%+5.8
FY2018Dec 31, 201827.4%−9.1
FY2017Dec 31, 201736.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202652.8%+1.2
Q1 FY2026Mar 31, 202648.6%+3.1
Q4 FY2025Dec 31, 202542.7%+0.9
Q3 FY2025Sep 30, 202545.7%+184.8
Q2 FY2025Jun 30, 202551.6%+18.4
Q1 FY2025Mar 31, 202545.5%+13.3
Q4 FY2024Dec 31, 202441.9%+19.1
Q3 FY2024Sep 30, 2024-139.1%−168.6
Q2 FY2024Jun 30, 202433.3%+6.6
Q1 FY2024Mar 31, 202432.2%+4.3
Q4 FY2023Dec 31, 202322.7%+0.8
Q3 FY2023Sep 30, 202329.5%+4.5
Q2 FY2023Jun 30, 202326.6%+4.6
Q1 FY2023Mar 31, 202327.9%+12.8
Q4 FY2022Dec 31, 202222.0%+18.2
Q3 FY2022Sep 30, 202225.1%+0.3
Q2 FY2022Jun 30, 202222.1%−15.3
Q1 FY2022Mar 31, 202215.1%−17.8
Q4 FY2021Dec 31, 20213.8%−25.8
Q3 FY2021Sep 30, 202124.8%−8.7
Q2 FY2021Jun 30, 202137.3%−11.7
Q1 FY2021Mar 31, 202132.9%+8.3
Q4 FY2020Dec 31, 202029.5%−9.8
Q3 FY2020Sep 30, 202033.5%+5.2
Q2 FY2020Jun 30, 202049.0%+20.5
Q1 FY2020Mar 31, 202024.6%−13.5
Q4 FY2019Dec 31, 201939.4%+13.8
Q3 FY2019Sep 30, 201928.3%+36.8
Q2 FY2019Jun 30, 201928.5%−18.0
Q1 FY2019Mar 31, 201938.1%−14.3
Q4 FY2018Dec 31, 201825.5%−21.9
Q3 FY2018Sep 30, 2018-8.5%−46.9
Q2 FY2018Jun 30, 201846.5%+21.1
Q1 FY2018Mar 31, 201852.4%+22.5
Q4 FY2017Dec 31, 201747.4%–
Q3 FY2017Sep 30, 201738.4%–
Q2 FY2017Jun 30, 201725.4%–
Q1 FY2017Mar 31, 201730.0%–

More Bionano Genomics figures

See a number that looks wrong?